On 28 May 2025, COST’s governing board, the Committee of Senior Officials (CSO) approved funding for seven new COST Innovators Grants (CIGs).
What is a COST Innovators Grant?
The COST Innovators Grant, as defined in the COST Strategic Plan, aims to enhance the pace and success of breakthrough innovations, build bridges between the scientific research performed in COST Actions and marketable applications and/or societal solutions, and explore innovation potential.
Launched in 2019 as a pilot scheme, CIGs are now a fully established feature for COST under Horizon Europe. Eligible COST Actions that are reaching the end of their initial 4-year funding period are invited to apply for CIG funding by the COST Association. CIGs have a duration of 12 months and grantees benefit from the same networking activities available to COST Actions.
Seven new COST Innovators Grants:
- A Venom-Based Discovery Pipeline for Innovation, Medicine and Sustainable Commercialization (IG19144)
- Developing a flexible and broadly applicable platform for expert guided cell-type deconvolution in human immune-related diseases (IG20117)
- INnovative DIgital COntrol for 3D Nanoprinting (IG20129)
- One-Stop Shop for Resilient, Future-proofed Urban Treescapes (IG20132)
- Setting up the Global Microwave link Data collection Initiative for hydrometeorological applications (IG20136)
- Capacity building for the next generation of researchers and evaluators to engage in inclusive sex and gendered research (IG20137)
- Predictive AI imaging for stem cell and organoids (IG20140)
The success rate for applications in this call was 15.6%.
The new CIGs will be starting their activities from 1 November. More information on the individual CIGs and their dedicated pages on the COST website will be coming soon.
Further information